|
Dr. May has more than 25 years as a pharmaceutical physician in the drug, medical device and biotechnology research industry in the US and Europe. He was responsible for multiple product approvals in a wide array of therapeutic areas. He was most recently with Esprit Pharma, a New Jersey-based company specializing in urology and women’s health and prior to that, with ESP Pharma, a company which focused on the hospital acute care area. Dr. May came to the US in 1980 as a visiting scientist at the Clinical Trials Branch of the National Heart, Lung, and Blood Institute in Bethesda, MD. He participated in a number of landmark cardiovascular studies. He also held senior research positions at Hoechst-Roussel (now Sanofi-Aventis), Pharmacia (now Pfizer), and Cytogen. He was previously a principal with the healthcare practice of Gemini Consulting, a leading management consulting company, and President of ClinTrials Research (now Kendle), a global contract research organization, where he oversaw US Operations. Dr. May has undergraduate and medical degrees from Cambridge University and is an Elected Fellow of the Faculty of Pharmaceutical Physicians. | 